Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
241 - 250 out of 415Page size: 10
Sort by: Title
  1. Published

    Liraglutide: a human GLP-1 analog for Type 2 diabetes

    Vilsbøll, Tina, 2009, In: Therapy. 6, 2, p. 199-207 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Liraglutide: a new treatment for type 2 diabetes

    Vilsbøll, Tina, 2009, In: Drugs of Today. 45, 2, p. 101-13 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Liraglutide: a once-daily GLP-1 analogue for the treatment of type 2 diabetes mellitus

    Vilsbøll, Tina, 1 Feb 2007, In: Expert Opinion on Investigational Drugs. 16, 2, p. 231-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Lixisenatide for type 2 diabetes mellitus

    Christensen, M., Knop, Filip Krag, Vilsbøll, Tina & Holst, Jens Juul, 2011, In: Expert Opinion on Investigational Drugs. 20, 4, p. 549-57 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus

    Vilsbøll, Tina & Knop, Filip Krag, 1 Jan 2008, In: BioDrugs. 22, 4, p. 251-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Long-term follow-up on patient-reported outcomes after supervised exercise training in individuals at risk of complications to type 2 diabetes

    Danielsen, J. H., Nielsen, S. G., Varming, A. R., Vilsbøll, Tina & Mølsted, Stig, 2024, In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 18, 2, 7 p., 102953.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

    Holst, Jens Juul, Knop, Filip Krag, Vilsbøll, Tina, Krarup, T. & Madsbad, Sten, May 2011, In: Diabetes Care. 34, Supplement 2, p. S251-7 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

    Jensen, J., Schou, Morten, Kistorp, Caroline Michaela Nervil, Faber, Jens, Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, Peter, Vilsbøll, Tina & Jørgensen, P. G., 2020, In: Cardiovascular Diabetology. 19, 1, 180.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Management of Patients with Type 2 Diabetes Shared between a Specialized Outpatient Clinic and General Practice Was Noninferior to Mono Management in a Specialized Outpatient Clinic—A Prospective, Randomized, Noninferiority Trial

    Munch, L., Bennich, B. B., Overgaard, D., Konradsen, Hanne, Middelfart, H. V., Kaarsberg, N., Knop, Filip Krag, Vilsbøll, Tina & Røder, M., 2018, In: Diabetes. 67, Supplement 1, 6-OR.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  10. Published

    Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

    Munch, L., Bennich, B. B., Overgaard, D., Konradsen, H., Middelfart, H., Kaarsberg, N., Knop, Filip Krag, Vilsbøll, Tina & Røder, M. E., 2019, In: Diabetic Medicine. 36, 7, p. 854-861

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...21 22 23 24 25 26 27 28 ...42 Next

ID: 33056950